世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Global Oncology API Market Growth 2026-2032
The global Oncology API market size is predicted to grow from US$ 32130 million in 2025 to US$ 52370 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032. Oncology API (Acti... もっと見る
SummaryThe global Oncology API market size is predicted to grow from US$ 32130 million in 2025 to US$ 52370 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.Oncology API (Active Pharmaceutical Ingredient) refers to the active substances used in the formulation of drugs specifically for the treatment of cancer. These APIs are used to target and treat various types of cancer through different mechanisms of action. They include chemotherapy agents, targeted therapies, hormonal treatments, and immunotherapies, each with specific mechanisms of action. The development, manufacturing, and regulatory oversight of these APIs are critical to ensuring their safety, efficacy, and availability for cancer patients. In 2024, the global production of oncology APIs will exceed 50,000 tons, with an average selling price of US$659,000 per ton. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LP Information, Inc. (LPI) ' newest research report, the “Oncology API Industry Forecast” looks at past sales and reviews total world Oncology API sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncology API sales for 2026 through 2032. With Oncology API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology API industry. This Insight Report provides a comprehensive analysis of the global Oncology API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology API market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology API. This report presents a comprehensive overview, market shares, and growth opportunities of Oncology API market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Alkylating Agents Antimetabolites Others Segmentation by Application: Chemotherapy Targeted Therapy Immunotherapy Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Teva Pharmaceutical Dr. Reddy’s Laboratories Cipla Hetero Johnson Matthey Glenmark Life Sciences Fresenius Kabi Sterling Mac-Chem Biocon Olon Shivalik Rasayan Concord Biotech Kekulepharma Aenova Sarv Biolabs Aspen Suanfarma Bachem Piramal Pharma Aurisco Pharmaceutical Shilpa Medicare Qilu Pharmaceutial Hengrui Hisun Zhejiang Xianju Junye Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Oncology API market? What factors are driving Oncology API market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Oncology API market opportunities vary by end market size? How does Oncology API break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Oncology API Annual Sales 2021-2032 2.1.2 World Current & Future Analysis for Oncology API by Geographic Region, 2021, 2025 & 2032 2.1.3 World Current & Future Analysis for Oncology API by Country/Region, 2021, 2025 & 2032 2.2 Oncology API Segment by Type 2.2.1 Alkylating Agents 2.2.2 Antimetabolites 2.2.3 Others 2.2.4 Oncology API Sales by Type 2.2.4.1 Global Oncology API Sales Market Share by Type (2021-2026) 2.2.4.2 Global Oncology API Revenue and Market Share by Type (2021-2026) 2.2.4.3 Global Oncology API Sale Price by Type (2021-2026) 2.3 Oncology API Segment by Application 2.3.1 Chemotherapy 2.3.2 Targeted Therapy 2.3.3 Immunotherapy 2.3.4 Others 2.3.5 Oncology API Sales by Application 2.3.5.1 Global Oncology API Sale Market Share by Application (2021-2026) 2.3.5.2 Global Oncology API Revenue and Market Share by Application (2021-2026) 2.3.5.3 Global Oncology API Sale Price by Application (2021-2026) 3 Global by Company 3.1 Global Oncology API Breakdown Data by Company 3.1.1 Global Oncology API Annual Sales by Company (2021-2026) 3.1.2 Global Oncology API Sales Market Share by Company (2021-2026) 3.2 Global Oncology API Annual Revenue by Company (2021-2026) 3.2.1 Global Oncology API Revenue by Company (2021-2026) 3.2.2 Global Oncology API Revenue Market Share by Company (2021-2026) 3.3 Global Oncology API Sale Price by Company 3.4 Key Manufacturers Oncology API Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Oncology API Product Location Distribution 3.4.2 Players Oncology API Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Oncology API by Geographic Region 4.1 World Historic Oncology API Market Size by Geographic Region (2021-2026) 4.1.1 Global Oncology API Annual Sales by Geographic Region (2021-2026) 4.1.2 Global Oncology API Annual Revenue by Geographic Region (2021-2026) 4.2 World Historic Oncology API Market Size by Country/Region (2021-2026) 4.2.1 Global Oncology API Annual Sales by Country/Region (2021-2026) 4.2.2 Global Oncology API Annual Revenue by Country/Region (2021-2026) 4.3 Americas Oncology API Sales Growth 4.4 APAC Oncology API Sales Growth 4.5 Europe Oncology API Sales Growth 4.6 Middle East & Africa Oncology API Sales Growth 5 Americas 5.1 Americas Oncology API Sales by Country 5.1.1 Americas Oncology API Sales by Country (2021-2026) 5.1.2 Americas Oncology API Revenue by Country (2021-2026) 5.2 Americas Oncology API Sales by Type (2021-2026) 5.3 Americas Oncology API Sales by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Oncology API Sales by Region 6.1.1 APAC Oncology API Sales by Region (2021-2026) 6.1.2 APAC Oncology API Revenue by Region (2021-2026) 6.2 APAC Oncology API Sales by Type (2021-2026) 6.3 APAC Oncology API Sales by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Oncology API by Country 7.1.1 Europe Oncology API Sales by Country (2021-2026) 7.1.2 Europe Oncology API Revenue by Country (2021-2026) 7.2 Europe Oncology API Sales by Type (2021-2026) 7.3 Europe Oncology API Sales by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Oncology API by Country 8.1.1 Middle East & Africa Oncology API Sales by Country (2021-2026) 8.1.2 Middle East & Africa Oncology API Revenue by Country (2021-2026) 8.2 Middle East & Africa Oncology API Sales by Type (2021-2026) 8.3 Middle East & Africa Oncology API Sales by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Oncology API 10.3 Manufacturing Process Analysis of Oncology API 10.4 Industry Chain Structure of Oncology API 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Oncology API Distributors 11.3 Oncology API Customer 12 World Forecast Review for Oncology API by Geographic Region 12.1 Global Oncology API Market Size Forecast by Region 12.1.1 Global Oncology API Forecast by Region (2027-2032) 12.1.2 Global Oncology API Annual Revenue Forecast by Region (2027-2032) 12.2 Americas Forecast by Country (2027-2032) 12.3 APAC Forecast by Region (2027-2032) 12.4 Europe Forecast by Country (2027-2032) 12.5 Middle East & Africa Forecast by Country (2027-2032) 12.6 Global Oncology API Forecast by Type (2027-2032) 12.7 Global Oncology API Forecast by Application (2027-2032) 13 Key Players Analysis 13.1 Teva Pharmaceutical 13.1.1 Teva Pharmaceutical Company Information 13.1.2 Teva Pharmaceutical Oncology API Product Portfolios and Specifications 13.1.3 Teva Pharmaceutical Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.1.4 Teva Pharmaceutical Main Business Overview 13.1.5 Teva Pharmaceutical Latest Developments 13.2 Dr. Reddy’s Laboratories 13.2.1 Dr. Reddy’s Laboratories Company Information 13.2.2 Dr. Reddy’s Laboratories Oncology API Product Portfolios and Specifications 13.2.3 Dr. Reddy’s Laboratories Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.2.4 Dr. Reddy’s Laboratories Main Business Overview 13.2.5 Dr. Reddy’s Laboratories Latest Developments 13.3 Cipla 13.3.1 Cipla Company Information 13.3.2 Cipla Oncology API Product Portfolios and Specifications 13.3.3 Cipla Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.3.4 Cipla Main Business Overview 13.3.5 Cipla Latest Developments 13.4 Hetero 13.4.1 Hetero Company Information 13.4.2 Hetero Oncology API Product Portfolios and Specifications 13.4.3 Hetero Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.4.4 Hetero Main Business Overview 13.4.5 Hetero Latest Developments 13.5 Johnson Matthey 13.5.1 Johnson Matthey Company Information 13.5.2 Johnson Matthey Oncology API Product Portfolios and Specifications 13.5.3 Johnson Matthey Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.5.4 Johnson Matthey Main Business Overview 13.5.5 Johnson Matthey Latest Developments 13.6 Glenmark Life Sciences 13.6.1 Glenmark Life Sciences Company Information 13.6.2 Glenmark Life Sciences Oncology API Product Portfolios and Specifications 13.6.3 Glenmark Life Sciences Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.6.4 Glenmark Life Sciences Main Business Overview 13.6.5 Glenmark Life Sciences Latest Developments 13.7 Fresenius Kabi 13.7.1 Fresenius Kabi Company Information 13.7.2 Fresenius Kabi Oncology API Product Portfolios and Specifications 13.7.3 Fresenius Kabi Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.7.4 Fresenius Kabi Main Business Overview 13.7.5 Fresenius Kabi Latest Developments 13.8 Sterling 13.8.1 Sterling Company Information 13.8.2 Sterling Oncology API Product Portfolios and Specifications 13.8.3 Sterling Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.8.4 Sterling Main Business Overview 13.8.5 Sterling Latest Developments 13.9 Mac-Chem 13.9.1 Mac-Chem Company Information 13.9.2 Mac-Chem Oncology API Product Portfolios and Specifications 13.9.3 Mac-Chem Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.9.4 Mac-Chem Main Business Overview 13.9.5 Mac-Chem Latest Developments 13.10 Biocon 13.10.1 Biocon Company Information 13.10.2 Biocon Oncology API Product Portfolios and Specifications 13.10.3 Biocon Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.10.4 Biocon Main Business Overview 13.10.5 Biocon Latest Developments 13.11 Olon 13.11.1 Olon Company Information 13.11.2 Olon Oncology API Product Portfolios and Specifications 13.11.3 Olon Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.11.4 Olon Main Business Overview 13.11.5 Olon Latest Developments 13.12 Shivalik Rasayan 13.12.1 Shivalik Rasayan Company Information 13.12.2 Shivalik Rasayan Oncology API Product Portfolios and Specifications 13.12.3 Shivalik Rasayan Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.12.4 Shivalik Rasayan Main Business Overview 13.12.5 Shivalik Rasayan Latest Developments 13.13 Concord Biotech 13.13.1 Concord Biotech Company Information 13.13.2 Concord Biotech Oncology API Product Portfolios and Specifications 13.13.3 Concord Biotech Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.13.4 Concord Biotech Main Business Overview 13.13.5 Concord Biotech Latest Developments 13.14 Kekulepharma 13.14.1 Kekulepharma Company Information 13.14.2 Kekulepharma Oncology API Product Portfolios and Specifications 13.14.3 Kekulepharma Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.14.4 Kekulepharma Main Business Overview 13.14.5 Kekulepharma Latest Developments 13.15 Aenova 13.15.1 Aenova Company Information 13.15.2 Aenova Oncology API Product Portfolios and Specifications 13.15.3 Aenova Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.15.4 Aenova Main Business Overview 13.15.5 Aenova Latest Developments 13.16 Sarv Biolabs 13.16.1 Sarv Biolabs Company Information 13.16.2 Sarv Biolabs Oncology API Product Portfolios and Specifications 13.16.3 Sarv Biolabs Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.16.4 Sarv Biolabs Main Business Overview 13.16.5 Sarv Biolabs Latest Developments 13.17 Aspen 13.17.1 Aspen Company Information 13.17.2 Aspen Oncology API Product Portfolios and Specifications 13.17.3 Aspen Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.17.4 Aspen Main Business Overview 13.17.5 Aspen Latest Developments 13.18 Suanfarma 13.18.1 Suanfarma Company Information 13.18.2 Suanfarma Oncology API Product Portfolios and Specifications 13.18.3 Suanfarma Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.18.4 Suanfarma Main Business Overview 13.18.5 Suanfarma Latest Developments 13.19 Bachem 13.19.1 Bachem Company Information 13.19.2 Bachem Oncology API Product Portfolios and Specifications 13.19.3 Bachem Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.19.4 Bachem Main Business Overview 13.19.5 Bachem Latest Developments 13.20 Piramal Pharma 13.20.1 Piramal Pharma Company Information 13.20.2 Piramal Pharma Oncology API Product Portfolios and Specifications 13.20.3 Piramal Pharma Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.20.4 Piramal Pharma Main Business Overview 13.20.5 Piramal Pharma Latest Developments 13.21 Aurisco Pharmaceutical 13.21.1 Aurisco Pharmaceutical Company Information 13.21.2 Aurisco Pharmaceutical Oncology API Product Portfolios and Specifications 13.21.3 Aurisco Pharmaceutical Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.21.4 Aurisco Pharmaceutical Main Business Overview 13.21.5 Aurisco Pharmaceutical Latest Developments 13.22 Shilpa Medicare 13.22.1 Shilpa Medicare Company Information 13.22.2 Shilpa Medicare Oncology API Product Portfolios and Specifications 13.22.3 Shilpa Medicare Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.22.4 Shilpa Medicare Main Business Overview 13.22.5 Shilpa Medicare Latest Developments 13.23 Qilu Pharmaceutial 13.23.1 Qilu Pharmaceutial Company Information 13.23.2 Qilu Pharmaceutial Oncology API Product Portfolios and Specifications 13.23.3 Qilu Pharmaceutial Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.23.4 Qilu Pharmaceutial Main Business Overview 13.23.5 Qilu Pharmaceutial Latest Developments 13.24 Hengrui 13.24.1 Hengrui Company Information 13.24.2 Hengrui Oncology API Product Portfolios and Specifications 13.24.3 Hengrui Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.24.4 Hengrui Main Business Overview 13.24.5 Hengrui Latest Developments 13.25 Hisun 13.25.1 Hisun Company Information 13.25.2 Hisun Oncology API Product Portfolios and Specifications 13.25.3 Hisun Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.25.4 Hisun Main Business Overview 13.25.5 Hisun Latest Developments 13.26 Zhejiang Xianju Junye Pharmaceutical 13.26.1 Zhejiang Xianju Junye Pharmaceutical Company Information 13.26.2 Zhejiang Xianju Junye Pharmaceutical Oncology API Product Portfolios and Specifications 13.26.3 Zhejiang Xianju Junye Pharmaceutical Oncology API Sales, Revenue, Price and Gross Margin (2021-2026) 13.26.4 Zhejiang Xianju Junye Pharmaceutical Main Business Overview 13.26.5 Zhejiang Xianju Junye Pharmaceutical Latest Developments 14 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Oncology API Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions) Table 2. Oncology API Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Alkylating Agents Table 4. Major Players of Antimetabolites Table 5. Major Players of Others Table 6. Global Oncology API Sales by Type (2021-2026) & (kg) Table 7. Global Oncology API Sales Market Share by Type (2021-2026) Table 8. Global Oncology API Revenue by Type (2021-2026) & ($ million) Table 9. Global Oncology API Revenue Market Share by Type (2021-2026) Table 10. Global Oncology API Sale Price by Type (2021-2026) & (US$/kg) Table 11. Global Oncology API Sale by Application (2021-2026) & (kg) Table 12. Global Oncology API Sale Market Share by Application (2021-2026) Table 13. Global Oncology API Revenue by Application (2021-2026) & ($ million) Table 14. Global Oncology API Revenue Market Share by Application (2021-2026) Table 15. Global Oncology API Sale Price by Application (2021-2026) & (US$/kg) Table 16. Global Oncology API Sales by Company (2021-2026) & (kg) Table 17. Global Oncology API Sales Market Share by Company (2021-2026) Table 18. Global Oncology API Revenue by Company (2021-2026) & ($ millions) Table 19. Global Oncology API Revenue Market Share by Company (2021-2026) Table 20. Global Oncology API Sale Price by Company (2021-2026) & (US$/kg) Table 21. Key Manufacturers Oncology API Producing Area Distribution and Sales Area Table 22. Players Oncology API Products Offered Table 23. Oncology API Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 24. New Products and Potential Entrants Table 25. Market M&A Activity & Strategy Table 26. Global Oncology API Sales by Geographic Region (2021-2026) & (kg) Table 27. Global Oncology API Sales Market Share Geographic Region (2021-2026) Table 28. Global Oncology API Revenue by Geographic Region (2021-2026) & ($ millions) Table 29. Global Oncology API Revenue Market Share by Geographic Region (2021-2026) Table 30. Global Oncology API Sales by Country/Region (2021-2026) & (kg) Table 31. Global Oncology API Sales Market Share by Country/Region (2021-2026) Table 32. Global Oncology API Revenue by Country/Region (2021-2026) & ($ millions) Table 33. Global Oncology API Revenue Market Share by Country/Region (2021-2026) Table 34. Americas Oncology API Sales by Country (2021-2026) & (kg) Table 35. Americas Oncology API Sales Market Share by Country (2021-2026) Table 36. Americas Oncology API Revenue by Country (2021-2026) & ($ millions) Table 37. Americas Oncology API Sales by Type (2021-2026) & (kg) Table 38. Americas Oncology API Sales by Application (2021-2026) & (kg) Table 39. APAC Oncology API Sales by Region (2021-2026) & (kg) Table 40. APAC Oncology API Sales Market Share by Region (2021-2026) Table 41. APAC Oncology API Revenue by Region (2021-2026) & ($ millions) Table 42. APAC Oncology API Sales by Type (2021-2026) & (kg) Table 43. APAC Oncology API Sales by Application (2021-2026) & (kg) Table 44. Europe Oncology API Sales by Country (2021-2026) & (kg) Table 45. Europe Oncology API Revenue by Country (2021-2026) & ($ millions) Table 46. Europe Oncology API Sales by Type (2021-2026) & (kg) Table 47. Europe Oncology API Sales by Application (2021-2026) & (kg) Table 48. Middle East & Africa Oncology API Sales by Country (2021-2026) & (kg) Table 49. Middle East & Africa Oncology API Revenue Market Share by Country (2021-2026) Table 50. Middle East & Africa Oncology API Sales by Type (2021-2026) & (kg) Table 51. Middle East & Africa Oncology API Sales by Application (2021-2026) & (kg) Table 52. Key Market Drivers & Growth Opportunities of Oncology API Table 53. Key Market Challenges & Risks of Oncology API Table 54. Key Industry Trends of Oncology API Table 55. Oncology API Raw Material Table 56. Key Suppliers of Raw Materials Table 57. Oncology API Distributors List Table 58. Oncology API Customer List Table 59. Global Oncology API Sales Forecast by Region (2027-2032) & (kg) Table 60. Global Oncology API Revenue Forecast by Region (2027-2032) & ($ millions) Table 61. Americas Oncology API Sales Forecast by Country (2027-2032) & (kg) Table 62. Americas Oncology API Annual Revenue Forecast by Country (2027-2032) & ($ millions) Table 63. APAC Oncology API Sales Forecast by Region (2027-2032) & (kg) Table 64. APAC Oncology API Annual Revenue Forecast by Region (2027-2032) & ($ millions) Table 65. Europe Oncology API Sales Forecast by Country (2027-2032) & (kg) Table 66. Europe Oncology API Revenue Forecast by Country (2027-2032) & ($ millions) Table 67. Middle East & Africa Oncology API Sales Forecast by Country (2027-2032) & (kg) Table 68. Middle East & Africa Oncology API Revenue Forecast by Country (2027-2032) & ($ millions) Table 69. Global Oncology API Sales Forecast by Type (2027-2032) & (kg) Table 70. Global Oncology API Revenue Forecast by Type (2027-2032) & ($ millions) Table 71. Global Oncology API Sales Forecast by Application (2027-2032) & (kg) Table 72. Global Oncology API Revenue Forecast by Application (2027-2032) & ($ millions) Table 73. Teva Pharmaceutical Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 74. Teva Pharmaceutical Oncology API Product Portfolios and Specifications Table 75. Teva Pharmaceutical Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Main Business Table 77. Teva Pharmaceutical Latest Developments Table 78. Dr. Reddy’s Laboratories Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 79. Dr. Reddy’s Laboratories Oncology API Product Portfolios and Specifications Table 80. Dr. Reddy’s Laboratories Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Dr. Reddy’s Laboratories Main Business Table 82. Dr. Reddy’s Laboratories Latest Developments Table 83. Cipla Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 84. Cipla Oncology API Product Portfolios and Specifications Table 85. Cipla Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Cipla Main Business Table 87. Cipla Latest Developments Table 88. Hetero Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 89. Hetero Oncology API Product Portfolios and Specifications Table 90. Hetero Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Hetero Main Business Table 92. Hetero Latest Developments Table 93. Johnson Matthey Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 94. Johnson Matthey Oncology API Product Portfolios and Specifications Table 95. Johnson Matthey Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Johnson Matthey Main Business Table 97. Johnson Matthey Latest Developments Table 98. Glenmark Life Sciences Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 99. Glenmark Life Sciences Oncology API Product Portfolios and Specifications Table 100. Glenmark Life Sciences Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 101. Glenmark Life Sciences Main Business Table 102. Glenmark Life Sciences Latest Developments Table 103. Fresenius Kabi Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 104. Fresenius Kabi Oncology API Product Portfolios and Specifications Table 105. Fresenius Kabi Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 106. Fresenius Kabi Main Business Table 107. Fresenius Kabi Latest Developments Table 108. Sterling Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 109. Sterling Oncology API Product Portfolios and Specifications Table 110. Sterling Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 111. Sterling Main Business Table 112. Sterling Latest Developments Table 113. Mac-Chem Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 114. Mac-Chem Oncology API Product Portfolios and Specifications Table 115. Mac-Chem Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 116. Mac-Chem Main Business Table 117. Mac-Chem Latest Developments Table 118. Biocon Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 119. Biocon Oncology API Product Portfolios and Specifications Table 120. Biocon Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 121. Biocon Main Business Table 122. Biocon Latest Developments Table 123. Olon Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 124. Olon Oncology API Product Portfolios and Specifications Table 125. Olon Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 126. Olon Main Business Table 127. Olon Latest Developments Table 128. Shivalik Rasayan Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 129. Shivalik Rasayan Oncology API Product Portfolios and Specifications Table 130. Shivalik Rasayan Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 131. Shivalik Rasayan Main Business Table 132. Shivalik Rasayan Latest Developments Table 133. Concord Biotech Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 134. Concord Biotech Oncology API Product Portfolios and Specifications Table 135. Concord Biotech Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 136. Concord Biotech Main Business Table 137. Concord Biotech Latest Developments Table 138. Kekulepharma Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 139. Kekulepharma Oncology API Product Portfolios and Specifications Table 140. Kekulepharma Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 141. Kekulepharma Main Business Table 142. Kekulepharma Latest Developments Table 143. Aenova Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 144. Aenova Oncology API Product Portfolios and Specifications Table 145. Aenova Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 146. Aenova Main Business Table 147. Aenova Latest Developments Table 148. Sarv Biolabs Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 149. Sarv Biolabs Oncology API Product Portfolios and Specifications Table 150. Sarv Biolabs Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 151. Sarv Biolabs Main Business Table 152. Sarv Biolabs Latest Developments Table 153. Aspen Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 154. Aspen Oncology API Product Portfolios and Specifications Table 155. Aspen Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 156. Aspen Main Business Table 157. Aspen Latest Developments Table 158. Suanfarma Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 159. Suanfarma Oncology API Product Portfolios and Specifications Table 160. Suanfarma Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 161. Suanfarma Main Business Table 162. Suanfarma Latest Developments Table 163. Bachem Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 164. Bachem Oncology API Product Portfolios and Specifications Table 165. Bachem Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 166. Bachem Main Business Table 167. Bachem Latest Developments Table 168. Piramal Pharma Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 169. Piramal Pharma Oncology API Product Portfolios and Specifications Table 170. Piramal Pharma Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 171. Piramal Pharma Main Business Table 172. Piramal Pharma Latest Developments Table 173. Aurisco Pharmaceutical Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 174. Aurisco Pharmaceutical Oncology API Product Portfolios and Specifications Table 175. Aurisco Pharmaceutical Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 176. Aurisco Pharmaceutical Main Business Table 177. Aurisco Pharmaceutical Latest Developments Table 178. Shilpa Medicare Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 179. Shilpa Medicare Oncology API Product Portfolios and Specifications Table 180. Shilpa Medicare Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 181. Shilpa Medicare Main Business Table 182. Shilpa Medicare Latest Developments Table 183. Qilu Pharmaceutial Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 184. Qilu Pharmaceutial Oncology API Product Portfolios and Specifications Table 185. Qilu Pharmaceutial Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 186. Qilu Pharmaceutial Main Business Table 187. Qilu Pharmaceutial Latest Developments Table 188. Hengrui Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 189. Hengrui Oncology API Product Portfolios and Specifications Table 190. Hengrui Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 191. Hengrui Main Business Table 192. Hengrui Latest Developments Table 193. Hisun Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 194. Hisun Oncology API Product Portfolios and Specifications Table 195. Hisun Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 196. Hisun Main Business Table 197. Hisun Latest Developments Table 198. Zhejiang Xianju Junye Pharmaceutical Basic Information, Oncology API Manufacturing Base, Sales Area and Its Competitors Table 199. Zhejiang Xianju Junye Pharmaceutical Oncology API Product Portfolios and Specifications Table 200. Zhejiang Xianju Junye Pharmaceutical Oncology API Sales (kg), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 201. Zhejiang Xianju Junye Pharmaceutical Main Business Table 202. Zhejiang Xianju Junye Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Oncology API Figure 2. Oncology API Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Oncology API Sales Growth Rate 2021-2032 (kg) Figure 7. Global Oncology API Revenue Growth Rate 2021-2032 ($ millions) Figure 8. Oncology API Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 9. Oncology API Sales Market Share by Country/Region (2025) Figure 10. Oncology API Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 11. Product Picture of Alkylating Agents Figure 12. Product Picture of Antimetabolites Figure 13. Product Picture of Others Figure 14. Global Oncology API Sales Market Share by Type in 2026 Figure 15. Global Oncology API Revenue Market Share by Type (2021-2026) Figure 16. Oncology API Consumed in Chemotherapy Figure 17. Global Oncology API Market: Chemotherapy (2021-2026) & (kg) Figure 18. Oncology API Consumed in Targeted Therapy Figure 19. Global Oncology API Market: Targeted Therapy (2021-2026) & (kg) Figure 20. Oncology API Consumed in Immunotherapy Figure 21. Global Oncology API Market: Immunotherapy (2021-2026) & (kg) Figure 22. Oncology API Consumed in Others Figure 23. Global Oncology API Market: Others (2021-2026) & (kg) Figure 24. Global Oncology API Sale Market Share by Application (2025) Figure 25. Global Oncology API Revenue Market Share by Application in 2026 Figure 26. Oncology API Sales by Company in 2026 (kg) Figure 27. Global Oncology API Sales Market Share by Company in 2026 Figure 28. Oncology API Revenue by Company in 2026 ($ millions) Figure 29. Global Oncology API Revenue Market Share by Company in 2026 Figure 30. Global Oncology API Sales Market Share by Geographic Region (2021-2026) Figure 31. Global Oncology API Revenue Market Share by Geographic Region in 2026 Figure 32. Americas Oncology API Sales 2021-2026 (kg) Figure 33. Americas Oncology API Revenue 2021-2026 ($ millions) Figure 34. APAC Oncology API Sales 2021-2026 (kg) Figure 35. APAC Oncology API Revenue 2021-2026 ($ millions) Figure 36. Europe Oncology API Sales 2021-2026 (kg) Figure 37. Europe Oncology API Revenue 2021-2026 ($ millions) Figure 38. Middle East & Africa Oncology API Sales 2021-2026 (kg) Figure 39. Middle East & Africa Oncology API Revenue 2021-2026 ($ millions) Figure 40. Americas Oncology API Sales Market Share by Country in 2026 Figure 41. Americas Oncology API Revenue Market Share by Country (2021-2026) Figure 42. Americas Oncology API Sales Market Share by Type (2021-2026) Figure 43. Americas Oncology API Sales Market Share by Application (2021-2026) Figure 44. United States Oncology API Revenue Growth 2021-2026 ($ millions) Figure 45. Canada Oncology API Revenue Growth 2021-2026 ($ millions) Figure 46. Mexico Oncology API Revenue Growth 2021-2026 ($ millions) Figure 47. Brazil Oncology API Revenue Growth 2021-2026 ($ millions) Figure 48. APAC Oncology API Sales Market Share by Region in 2026 Figure 49. APAC Oncology API Revenue Market Share by Region (2021-2026) Figure 50. APAC Oncology API Sales Market Share by Type (2021-2026) Figure 51. APAC Oncology API Sales Market Share by Application (2021-2026) Figure 52. China Oncology API Revenue Growth 2021-2026 ($ millions) Figure 53. Japan Oncology API Revenue Growth 2021-2026 ($ millions) Figure 54. South Korea Oncology API Revenue Growth 2021-2026 ($ millions) Figure 55. Southeast Asia Oncology API Revenue Growth 2021-2026 ($ millions) Figure 56. India Oncology API Revenue Growth 2021-2026 ($ millions) Figure 57. Australia Oncology API Revenue Growth 2021-2026 ($ millions) Figure 58. China Taiwan Oncology API Revenue Growth 2021-2026 ($ millions) Figure 59. Europe Oncology API Sales Market Share by Country in 2026 Figure 60. Europe Oncology API Revenue Market Share by Country (2021-2026) Figure 61. Europe Oncology API Sales Market Share by Type (2021-2026) Figure 62. Europe Oncology API Sales Market Share by Application (2021-2026) Figure 63. Germany Oncology API Revenue Growth 2021-2026 ($ millions) Figure 64. France Oncology API Revenue Growth 2021-2026 ($ millions) Figure 65. UK Oncology API Revenue Growth 2021-2026 ($ millions) Figure 66. Italy Oncology API Revenue Growth 2021-2026 ($ millions) Figure 67. Russia Oncology API Revenue Growth 2021-2026 ($ millions) Figure 68. Middle East & Africa Oncology API Sales Market Share by Country (2021-2026) Figure 69. Middle East & Africa Oncology API Sales Market Share by Type (2021-2026) Figure 70. Middle East & Africa Oncology API Sales Market Share by Application (2021-2026) Figure 71. Egypt Oncology API Revenue Growth 2021-2026 ($ millions) Figure 72. South Africa Oncology API Revenue Growth 2021-2026 ($ millions) Figure 73. Israel Oncology API Revenue Growth 2021-2026 ($ millions) Figure 74. Turkey Oncology API Revenue Growth 2021-2026 ($ millions) Figure 75. GCC Countries Oncology API Revenue Growth 2021-2026 ($ millions) Figure 76. Manufacturing Cost Structure Analysis of Oncology API in 2026 Figure 77. Manufacturing Process Analysis of Oncology API Figure 78. Industry Chain Structure of Oncology API Figure 79. Channels of Distribution Figure 80. Global Oncology API Sales Market Forecast by Region (2027-2032) Figure 81. Global Oncology API Revenue Market Share Forecast by Region (2027-2032) Figure 82. Global Oncology API Sales Market Share Forecast by Type (2027-2032) Figure 83. Global Oncology API Revenue Market Share Forecast by Type (2027-2032) Figure 84. Global Oncology API Sales Market Share Forecast by Application (2027-2032) Figure 85. Global Oncology API Revenue Market Share Forecast by Application (2027-2032)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
LP Information社の 医薬品・ヘルスケア分野 での最新刊レポート
本レポートと同じKEY WORD（oncology）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
